The study findings indicated that variant-modified booster vaccines could result in significantly higher neutralization titers against prevalent and ancestral SARS-CoV-2 variants compared to ancestral-based boosters.
While BA.4.6 has been in the U.S. since at least May, it remained below 2% of new cases sequenced until July, when it gradually began to rise, even as BA.5 continued to do the same. As of this week’s CDC reporting, it currently stands at 7.5%. But the real wrinkle comes when the variant proportions are broken out regionally.
"We’re not going to eradicate the virus from the face of the Earth," Fauci told Yahoo Finance in an interview on Tuesday. “I don’t believe we’re even going to eliminate it from this country to the tune of getting zero cases."
At the very moment a better coronavirus vaccine is expected to finally become available, America’s vaccination program is feeling the effects of a long period of retreat.
Local programs to bring shots to the places where Americans gather and the institutions they trust have folded, a consequence in some cases of congressional resistance to more pandemic response spending.
Recent Comments